Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis.

Yang Z, Li W, Liu Y, Wei M, Li Z, Yan L, Guo Z, Lv Y, Li F, Zhou W, Huang W.

Open source

DOI
10.1016/j.intimp.2026.117347
Published
2026-09-01
Container
Int Immunopharmacol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117347,
  title = {Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis.},
  author = {Yang Z and  Li W and  Liu Y and  Wei M and  Li Z and  Yan L and  Guo Z and  Lv Y and  Li F and  Zhou W and  Huang W.},
  year = {2026},
  journal = {Int Immunopharmacol},
  doi = {10.1016/j.intimp.2026.117347},
  url = {https://doi.org/10.1016/j.intimp.2026.117347}
}

RIS

TY  - JOUR
TI  - Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis.
AU  - Yang Z
AU  -  Li W
AU  -  Liu Y
AU  -  Wei M
AU  -  Li Z
AU  -  Yan L
AU  -  Guo Z
AU  -  Lv Y
AU  -  Li F
AU  -  Zhou W
AU  -  Huang W.
PY  - 2026
JO  - Int Immunopharmacol
DO  - 10.1016/j.intimp.2026.117347
UR  - https://doi.org/10.1016/j.intimp.2026.117347
ER  - 

APA

Z, Y., W, L., Y, L., M, W., Z, L., L, Y., Z, G., Y, L., F, L., W, Z., & W., H. (2026). Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis.. Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2026.117347

Source records